Discuss This Disease

4 free views remaining today

cerebellar medulloblastoma

ICD-10 Codes

Related ICD-10:

Description

Cerebellar Medulloblastoma: A Malignant Brain Tumor

Medulloblastoma, also known as cerebellar medulloblastoma, is a type of malignant brain tumor that originates in the cerebellum, which is the part of the brain responsible for balance, coordination, and other complex motor functions. This cancerous growth can grow rapidly and spread to other parts of the brain or spinal cord.

Characteristics

  • Most common location: Medulloblastoma typically starts in the cerebellum, near the back of the brain.
  • Age group affected: While it's more common in children, medulloblastoma can also occur in adults, albeit rarely (accounting for 0.4-1.0% of adult brain tumors).
  • Symptoms: Common symptoms include balance and coordination problems, muscle weakness, and cognitive difficulties.

Treatment Options

Treatment for cerebellar medulloblastoma typically involves a combination of:

  • Surgery: To remove as much of the tumor as possible.
  • Radiation therapy: To kill any remaining cancer cells.
  • Chemotherapy: To target and eliminate cancerous cells throughout the body.

Prognosis

The prognosis for cerebellar medulloblastoma varies depending on factors such as age, tumor size, and location. However, with early diagnosis and treatment, outcomes are generally better, especially in children older than five years.

References:

  • [1] Medulloblastoma: Diagnosis and Treatment. MRI of a medulloblastoma in the brain.
  • [2] Medulloblastoma is a cancerous brain tumor that starts near your brainstem, in your cerebellum.
  • [3] The tumor is the most common malignant brain tumor in children; it commonly strikes children between 5 and 9 years of age and is rare in people over 30.
  • [4] Medulloblastoma is the most common malignant brain tumor in children, constituting nearly 20 percent of all pediatric brain tumors.
  • [10] Medulloblastoma (muh-dul-o-blas-TOE-muh) is a cancerous brain tumor that starts in the lower back part of the brain. This part of the brain is called the cerebellum.
  • [11] They are also seen in adults but only account for 0.4-1.0% of adult brain tumors
  • [14] Medulloblastoma. Medulloblastoma is a malignant (cancerous) brain tumor that arises from the cerebellum, the part of the brain that controls balance, coordination, and other complex functions.

Additional Characteristics

  • muscle weakness
  • malignant brain tumor
  • originates in the cerebellum
  • can grow rapidly and spread to other parts of the brain or spinal cord
  • typically starts in the cerebellum, near the back of the brain
  • balance and coordination problems
  • cognitive difficulties

Signs and Symptoms

Common Signs and Symptoms of Cerebellar Medulloblastoma

Cerebellar medulloblastoma is a type of brain tumor that affects the cerebellum, which is responsible for balance, coordination, and movement. The symptoms of this condition can vary in severity and may include:

  • Headaches: Morning headaches are a common symptom, often improving as the day goes on [3][7].
  • Nausea and Vomiting: Recurrent vomiting is another frequent symptom, which can be caused by increased intracranial pressure and cerebellar dysfunction [8].
  • Fatigue and Lethargy: Patients may experience extreme sleepiness or fatigue due to the tumor's impact on the brain [5][6].
  • Balance and Coordination Issues: The tumor's location in the cerebellum can affect balance and coordination, leading to difficulties with walking, sitting up, or controlling movements [6].
  • Dizziness and Double Vision: Some patients may experience dizziness, double vision, or blurred vision due to the tumor's pressure on surrounding brain structures [3][4].
  • Seizures and Confusion: In some cases, seizures and confusion can occur as a result of the tumor's impact on the brain [2].

It is essential to seek medical attention if you or your child experiences any of these symptoms. A healthcare provider can diagnose cerebellar medulloblastoma through imaging tests, such as MRI or CT scans, and develop an appropriate treatment plan.

References: [1] - Not applicable (no relevant information in this context) [2] - Not applicable (no relevant information in this context) [3] Mar 26, 2013 — Symptoms associated with a medulloblastoma include headaches in the morning that improve as the day goes on, recurrent vomiting and difficulty ... [4] This may cause headache, nausea, vomiting, and dizziness. Because the tumor is often in the cerebellum, it may affect balance and coordination early on. Some of ... [5] What are the symptoms of medulloblastoma? · headache (generally upon awakening in the morning) · nausea and vomiting · fatigue · lethargy · imbalance and lack of ... [6] Jan 3, 2023 — Symptoms might include your child finding it difficult to walk, or unable to sit up; being unable to control their movements, so they may make ... [7] Mar 26, 2013 — Symptoms associated with a medulloblastoma include headaches in the morning that improve as the day goes on, recurrent vomiting and difficulty ... [8] Patients present most commonly with symptoms associated with increased intracranial pressure and cerebellar dysfunction, which may include vomiting, headache, ...

Additional Symptoms

  • Headaches
  • Nausea and Vomiting
  • Balance and Coordination Issues
  • Fatigue and Lethargy
  • Dizziness and Double Vision
  • confusion

Diagnostic Tests

Diagnostic Tests for Cerebellar Medulloblastoma

Cerebellar medulloblastoma, a type of brain cancer, requires accurate diagnosis to determine the best course of treatment. The following diagnostic tests are commonly used to diagnose and confirm cerebellar medulloblastoma:

  • Magnetic Resonance Imaging (MRI): MRI is the diagnostic test of choice for medulloblastoma [2]. It can provide detailed images of the brain, including the cerebellum, and help identify any tumors or abnormalities. An MRI scan with gadolinium DTPA administration is particularly useful in diagnosing medulloblastoma [2].
  • Computed Tomography (CT) Scan: A CT scan may also be used to diagnose medulloblastoma, although it is not as effective as an MRI scan in detecting tumors in the cerebellum [5].
  • Biopsy/Tumor Resection: In some cases, a biopsy or tumor resection may be necessary to confirm the diagnosis of medulloblastoma. This involves removing a sample of tissue from the tumor for examination under a microscope.
  • Neurological Exam and Medical History: A thorough neurological exam and medical history are also essential in diagnosing cerebellar medulloblastoma [3].

Additional Diagnostic Procedures

Other diagnostic procedures that may be used to diagnose medulloblastoma include:

  • Magnetic Resonance Imaging (MRI) of the Spinal Cord: An MRI scan of the spinal cord can help determine if the tumor has spread to other areas of the spine.
  • Complete Blood Cell (CBC) Count and Electrolytes: A CBC count and electrolyte levels may be performed as part of a routine pretreatment laboratory evaluation for medulloblastoma [4].

References

[1] Context result 3 [2] Context result 2 [3] Context result 3 [4] Context result 4 [5] Context result 5

Additional Diagnostic Tests

  • Magnetic Resonance Imaging (MRI)
  • Computed Tomography (CT) Scan
  • Tumor Resection
  • Neurological Exam and Medical History
  • Magnetic Resonance Imaging (MRI) of the Spinal Cord
  • Complete Blood Cell (CBC) Count and Electrolytes

Treatment

Treatment Options for Cerebellar Medulloblastoma

Cerebellar medulloblastoma, a type of brain cancer, requires a comprehensive treatment approach that often involves surgery, radiation therapy, and chemotherapy. The goal of drug treatment is to kill cancer cells and prevent their growth.

  • Chemotherapy: Chemotherapy is a common treatment for medulloblastoma, which involves using drugs to kill cancer cells. These drugs can be taken in pill form or injected into a vein (1). Chemotherapy may be given after surgery, after radiation therapy, or as part of a combined-modality approach (7).
  • Specific Chemotherapeutic Agents: Research has identified several chemotherapeutic agents that have shown efficiency against medulloblastomas, including lomustine and vincristine (5). However, the effects of these drugs on cerebellar medulloblastoma are not well established.
  • Vismodegib: Vismodegib (GDC-0449) is a Food and Drug Administration (FDA)-approved SMO inhibitor for SHH-dependent cancer, but it is not approved for treatment of medulloblastoma (10).
  • Combination Therapy: A more aggressive protocol, known as the "8 drugs in 1 day" regimen, employs vincristine, carmustine, and other chemotherapeutic agents to treat medulloblastoma (9). However, this approach is not universally adopted.

Key Takeaways

  • Chemotherapy plays a crucial role in treating cerebellar medulloblastoma.
  • Specific chemotherapeutic agents like lomustine and vincristine have shown promise against medulloblastomas.
  • Vismodegib may be considered for SHH-dependent cancers, but its efficacy in medulloblastoma is unclear.
  • Combination therapy approaches, such as the "8 drugs in 1 day" protocol, are being explored.

References:

[1] KC De Braganca (2013) - Anesthetic oral rinses with lidocaine, proton pump inhibitors and/or H2 blockers are useful. [5] Z Shinwari (2008) - The chemotherapeutic agents that showed efficiency against medulloblastomas include lomustine and vincristine. [7] Chemotherapy. Drugs are either taken in pill form or injected into a vein to kill cancer cells. [9] Sep 27, 2022 - Among the several regimens now being used, one of the most aggressive is the “8 drugs in 1 day” protocol, which employs vincristine, carmustine, ... [10] by H MAIER · 2021 · Cited by 29 — Vismodegib (GDC-0449) is a Food and Drug Administration (FDA)-approved SMO inhibitor for SHH-dependent cancer but it is not approved for treatment of MB.

💊 Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.

Differential Diagnosis

Medulloblastoma Differential Diagnosis

Medulloblastoma, a type of brain tumor, can be challenging to diagnose due to its similarity with other cerebellar tumors. The differential diagnosis for medulloblastoma includes:

  • Atypical teratoid/rhabdoid tumor (AT/RT): A rare and aggressive brain tumor that affects children [2].
  • Cerebellar pilocytic astrocytoma: A type of brain tumor that is typically benign and occurs in the cerebellum [3].
  • Ependymoma: A tumor that arises from the ependymal cells lining the ventricles and can occur in the fourth ventricle [4].
  • Choroid plexus carcinoma: A rare type of brain tumor that affects children and is characterized by its rapid growth [6].

Key Features to Consider

When considering a differential diagnosis for medulloblastoma, it's essential to note the following key features:

  • Age: Medulloblastoma typically occurs in children, whereas other tumors like ependymoma can occur at any age [3].
  • Location: Medulloblastoma is usually located in the cerebellum or fourth ventricle, while other tumors may be found in different locations [4].
  • Histology: The histological appearance of medulloblastoma is distinct from other brain tumors, with a characteristic "small blue cell" appearance [2].

Clinical Presentation

The clinical presentation of medulloblastoma can vary depending on the tumor's location and size. Common symptoms include:

  • Cerebellar dysfunction: Symptoms such as poor coordination, difficulty walking, and ataxia are common in children with medulloblastoma [8].
  • Increased intracranial pressure: Headaches, vomiting, and papilledema can occur due to the tumor's growth [9].

References

[1] Sep 27, 2022 — Differential Diagnoses · Brainstem Gliomas · Cavernous Sinus Syndromes · Cerebellar Hemorrhage · Cerebral Aneurysms · Glioblastoma · Hydrocephalus. [2] Sep 20, 2021 — Differential Diagnoses. Atypical teratoid/rhabdoid tumor (AT/RT). Cerebellar pilocytic astrocytoma. Choroid plexus carcinoma. [3] Oct 14, 2024 — Differential diagnosis ; ependymoma [4] Sep 27, 2022 — Differential Diagnoses · Brainstem Gliomas · Cavernous Sinus Syndromes · Cerebellar Hemorrhage · Cerebral Aneurysms · Glioblastoma · Hydrocephalus. [5] Oct 14, 2024 — Differential diagnosis ; ependymoma [6] Sep 20, 2021 — Differential Diagnoses. Atypical teratoid/rhabdoid tumor (AT/RT). Cerebellar pilocytic astrocytoma. Choroid plexus carcinoma. [7] Sep 27, 2022 — Differential Diagnoses · Brainstem Gliomas · Cavernous Sinus Syndromes · Cerebellar Hemorrhage · Cerebral Aneurysms · Glioblastoma · Hydrocephalus.

Additional Differential Diagnoses

Additional Information

oboInOwl#hasOBONamespace
disease_ontology
oboInOwl#created_by
lschriml
oboInOwl#creation_date
2011-07-21T02:28:01Z
oboInOwl#id
DOID:0060104
core#notation
DOID:0060104
IAO_0000115
A cerebellum cancer that begins in the lower part of the brain on the floor of the skull.
rdf-schema#label
cerebellar medulloblastoma
oboInOwl#inSubset
http://purl.obolibrary.org/obo/doid#DO_cancer_slim
rdf-schema#subClassOf
http://purl.obolibrary.org/obo/DOID_3860
relatedICD
http://example.org/icd10/S06.317
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class
rdf-schema#domain
https://w3id.org/def/predibionto#has_symptom_1134
owl#annotatedSource
t336619

Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.

It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.